SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001213900-20-040941
Filing Date
2020-12-04
Accepted
2020-12-04 08:30:51
Documents
3
Group Members
EDWARD TERINOJAMES C. ROUMELLMATTHEW M. LOAR

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13D ea130884-13da1roumell_enzo.htm SC 13D/A 104545
2 LETTER TO THE SEC, DATED DECEMBER 4, 2020 ea130884ex99-1_enzo.htm EX-99.1 17227
3 POWER OF ATTORNEY OF JAMES C. ROUMELL, DATED DECEMBER 4, 2020 ea130884ex99-2_enzo.htm EX-99.2 9088
  Complete submission text file 0001213900-20-040941.txt   132457
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Subject) CIK: 0000316253 (see all company filings)

IRS No.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: SC 13D/A | Act: 34 | File No.: 005-32878 | Film No.: 201368772
SIC: 8071 Services-Medical Laboratories

Mailing Address 2 WISCONSIN CIR SUITE 640 CHEVY CHASE MD 20815
Business Address 2 WISCONSIN CIR SUITE 640 CHEVY CHASE MD 20815 301-656-8500
Roumell Asset Management, LLC (Filed by) CIK: 0001331693 (see all company filings)

IRS No.: 522145132 | State of Incorp.: MD | Fiscal Year End: 1231
Type: SC 13D/A